The Impact of Research Quality and Study Design on Epidemiologic Estimates of the Effect of Nonsteroidal Anti-inflammatory Drugs on Upper Gastrointestinal Tract Disease

Archives of Internal Medicine

Volumn 152, Issue 6, 1992, Pages 1289-1295

  Bollini, Paola ^a,b   Rodríguez, Luis A García ^c   Gutthann, Susanne Pérez ^c   Walker, Alexander M ^a  

^a Department of Population Sciences ^*  (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c CIBA GEIGY LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

AGING; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CASE CONTROL STUDY; DRUG EFFECT; DRUG EXPOSURE; GASTROINTESTINAL DISEASE; HUMAN; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CASE-CONTROL STUDIES; COHORT STUDIES; EPIDEMIOLOGIC METHODS; FEMALE; GASTROINTESTINAL DISEASES; HUMAN; MALE; META-ANALYSIS; MIDDLE AGE; RESEARCH DESIGN; RISK FACTORS; SUPPORT, NON-U.S. GOV'T;

EID: 0026633726     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.1992.00400180139023     Document Type: Article

References (54)

1. Soll AH, Kurata J, McGuigan JE. Ulcers, nonsteroidal antiinflammatory drugs, and related matters. Gastroenterology. 1989;96:561-568.
2. Champion GD. A perspective on the cost-effectiveness and risks of non-steroidal anti-inflammatory drug therapy. Med J Aust. 1988;149:346-349.
3. Chalmers TC, Berrier J, Hewitt P, et al. Meta-analysis of randomized controlled trials as a method of estimating rare complications of non-steroidal anti-inflammatory drug therapy. Aliment Pharmacol Ther. 1988;2S:9-26.
4. Hawkey CJ. Non-steroidal anti-inflammatory drugs and peptic ulcers: facts and figures multiply, but do they add up? BMJ. 1990;300:278-284.
5. Gabriel SE, Bombardier C. NSAID induced ulcers: an emerging epidemic? J Rheumatol. 1990;17:1-4.
6. Bracken MB. Reporting observational studies. Br J Obstet Gynecol. 1989;96:383-388.
7. Lichtenstain MJ, Mulrow C, Elwood P. Guidelines for reading case-control studies. J Chronic Dis. 1987;40:893-903.
8. Jick H, Vessey MP. Case-control studies in the evaluation of druginduced illness. Am J Epidemiol. 1978;107:1-7.
9. Longnecker MP, Berlin JA, Orza MJ, Chalmers TC. A meta-analysis of alcohol consumption in relation to risk of breast cancer. JAMA. 1988;260:652-656.
10. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clin Trials. 1986;7:177-188.
11. Gaillard C, Borel GA, De Peyer R, Loizeau E. Atteintes peptiques du tractus difestif superieur et medicaments. Schweiz Med Wochenschr. 1984;114:56-57.
12. Martio J. The influence of antirheumatic drugs on the occurrence of peptic ulcer. Scand J Rheumatol. 1980;9:55-59.
13. Coggon D, Langman MJS, Spiegelhalter D. Aspirin, paracetamol and haematemesis and melaena. Gut. 1982;23:340-344.
14. Allibone A, Flint FJ. Bronchitis, aspirin, smoking and other factors in the aetiology of peptic ulcer. Lancet. 1958;2:179-182.
15. Alvarez AS, Summerskill WHG. Gastrointestinal haemorrhage and salicylates. Lancet. 1958;2:920-925.
16. Armstrong CP, Blower AL. Non-steroidal anti-inflammatory drugs and life-threatening complications of peptic ulcerations. Gut. 1987;28:527-532.
17. Bartle WR, Gupta AK, Laxor J. Non-steroidal anti-inflammatory drugs and gastrointestinal bleeding: a case-control study. Arch Intern Med. 1986;146:2365-2367.
18. Beard K, Walker AM, Perera D, Jick H. Non-steroidal anti-inflammatory drugs and hospitalization for gastroesophageal bleeding in the elderly. Arch Intern Med. 1987;147:1621-1623.
19. Beardon PHG, Brown SW, McDevitt DG. Gastrointestinal events in patients prescribed non-steroidal anti-inflammatory drugs: a controlled study record linkage in Tayside. Q J Med. 1989;71:497-505.
20. Bloom BS. Risk and cost of gastrointestinal side effects associated with non-steroidal anti-inflammatory drugs. Arch Intern Med. 1989;149:1019-1022.
21. Caradoc-Davies TH. Non-steroidal anti-inflammatory drugs, arthritis, and gastrointestinal bleeding in elderly inpatients. Age Ageing. 1984;13:295-298.
22. Carson JL, Strom BL, Soper KA, West SL, Morse ML. The association of non-steroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding. Arch Intern Med. 1987;147:85-88.
23. Clinch D, Banerjee AK, Levy DW, Ostick G, Faragher EB. Nonsteroidal anti-inflammatory drugs and peptic ulceration. J R Coll Physicians Lond. 1987;21:183-187.
24. Collier DSJ, Pain JA. Non-steroidal anti-inflammatory drugs and peptic ulcer perforation. Gut. 1985;26:359-363.
25. Duggan JM, Dobson AJ, Johnson H, Fahey P. Peptic ulcer and non-steroidal anti-inflammatory agents. Gut. 1986;27:929-933.
26. Faulkner G, Prichard P, Sommerville K, Langman MJS. Aspirin and bleeding peptic ulcers in the elderly. BMJ. 1988;297:1311-1313.
27. Fries JF, Miller SR, Spitz PW, et al. Toward an epidemiology of gastropathy associated with non-steroidal anti-inflammatory drug use. Gastroenterology. 1989;96:647-655.
28. Gillies M, Skyring A. Gastric ulcer, duodenal ulcer and gastric carcinoma: a case-control study of certain social and environmental factors. Med J Aust. 1968;2:1132-1136.
29. Guess HA, West R, Strand LM, et al. Fatal upper gastrointestinal hemorrhage or perforation among users and nonusers of antiinflammatory drugs in Saskatchewan, Canada 1983. J Clin Epidemiol. 1988;41:35-45.
30. Jick S, Perera D, Walker A, Jick H. Non-steroidal antiinflammatory drugs and hospital admission for perforated peptic ulcer. Lancet. 1987;2:380-382.
31. Kelly JJ. Salicylate ingestion: a frequent cause of gastric haemorrhage. Am J Med Sci. 1956;232:119-128.
32. Langman MJS, Coggon D, Spiegelhalter D. Analgesic intake and the risk of acute upper gastrointestinal bleeding. Am J Med. 1983;74:79-82.
33. Levy M. Aspirin use in patients with major upper gastrointestinal bleeding and peptic ulcer disease. N Engl J Med. 1974;290:1158-1162.
34. Levy M, Miller D, Kaufman DW, et al. Major upper gastrointestinal tract bleeding: relation to the use of aspirin and other nonnarcotic analgesics. Arch Intern Med. 1988;148:281-285.
35. McIntosh JH, Byth K, Piper DW. Environmental factors in the etiology of chronic gastric ulcer: a case-control study of exposure variables before the first symptoms. Gut. 1985;26:789-798.
36. Muir A, Cossar IA. Aspirin and gastric haemorrhage. Lancet. 1959;1:539-541.
37. Needham CD, Kyle J, Jones PF, Johnston SJ, Kerridge DF. Aspirin and alcohol in gastrointestinal haemorrhage. Gut. 1971;12:819-821.
38. Paganini-Hill A, Chao A, Ross RK, Henderson BE. Aspirin use and chronic diseases: a cohort study of the elderly. BMJ. 1989;299:1247.
39. Parry DJ, Wood PHN. Relationship between aspirin taking and gastroduodenal haemorrhage. Gut. 1967;8:301-307.
40. Piper DW, McIntosh JH, Ariotti DE, Fenton BH, McLennan R. Analgesic ingestion and chronic peptic ulcer. Gastroenterology. 1981;80:427-432.
41. Smedley FH, Taube M, Wastell C. Non-steroidal antiinflammatory drugs ingestion: retrospective study of 272 bleeding or perforated peptic ulcers. Postgrad Med J. 1989;65:892-895.
42. Sommerville K, Faulkner G, Langman M. Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet. 1986;1:462-464.
43. Stodolnik E, Maurer P, Hess T, et al. Risk of acute upper gastrointestinal bleeding in patients with ulcerative disease and treatment with non-steroidal anti-inflammatory drugs. Eur J Clin Pharmacol. 1990;38:31-35.
44. Thompson MR. Indomethacin and perforated duodenal ulcer. BMJ. 1980;280:448.
45. Valman HB, Parry DJ, Coghill NF. Lesions associated with gastrointestinal haemorrhage, in relation to aspirin intake. BMJ. 1968;4:661-663.
46. Griffin MR, Ray WA, Schaffner W. Non-steroidal anti-inflammatory drugs and death from peptic ulcer in elderly persons. Ann Intern Med. 1988;109:359-363.
47. Quader K, Logan FA. Peptic ulcer deaths: how many occur at home or after non-steroidal anti-inflammatory drugs prescribing. Gut. 1988;29:A1443. Abstract.
48. Glass GV. Primary, secondary, and meta-analysis of research. Educ Res. 1976;5:3-8.
49. Wachter KW. Disturbed by meta-analysis. Science. 1988;241:1407-1408.
50. Sacks HS, Berrier J, Reitman D, Ancona-Berk VA, Chalmers TC. Meta-analysis of randomized controlled trials. N Engl J Med. 1987;316:450-455.
51. L’Abbe KA, Detsky AS, O’Rourke K. Meta-analysis in clinical research. Ann Intern Med. 1987;107:224-233.
52. Jenicek M. Meta-analysis in medicine: where we are and where we want to go. J Clin Epidemiol. 1989;42:35-44.
53. Emerson JD, Burdick E, Hoaglin DC, Mosteller F, Chalmers TC. An empirical study of the possible relation of treatment differences to quality scores in controlled randomized clinical trials. Controlled Clin Trials. 1990;11:339-352.
54. Berlin JA, Colditz GA. A meta-analysis of physical activity in the prevention of coronary heart disease. Am J Epidemiol. 1990;132:612-628.